Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1612 1636 1639 1653 1675 1678 1682 1684
This examiner grants 64% of resolved cases
Christopher M Gross is a senior examiner in Tech Center 1600, specifically Art Unit 1612, with 669 resolved cases. His allowance rate of 63.5 percent indicates a generally positive outlook for applicants, with a majority of cases reaching a grant. This large sample size provides a high degree of confidence in the examiner's prosecution patterns within the biotechnology and organic chemistry fields.
The interview lift of 40.2 percent is particularly striking, suggesting that oral advocacy is exceptionally effective with this examiner. This high lift indicates that an interview can dramatically increase the chances of an allowance, likely by resolving complex technical issues that are difficult to address solely through written correspondence. Practitioners should strongly consider scheduling interviews early in the process.
The median days to allowance is 1542, which is a significantly longer timeline than many other units. This duration of over four years suggests that while the eventual probability of grant is good, the process is likely to involve extensive examination and multiple office actions. Applicants should be prepared for a long-term engagement when their cases are assigned to Art Unit 1612.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17182044 | GENE EXPRESSION-BASED BIOMARKER FOR THE DETECTION AND MONITORING OF BRONCHIAL PREMALIGNANT LESIONS | Non-Final OA | Trustees of Boston University |
| 18189056 | COMBINATORIAL PLATFORM FOR HIGH-THROUGHPUT POLYNUCLEOTIDE-ENCODED CATALYST DISCOVERY | Final Rejection | WISCONSIN ALUMNI RESEARCH FOUNDATION |
| 18051711 | METHOD TO QUANTIFY AFFINITY AND SELECTIVITY OF SMALL MOLECULES FOR PROTEINS IN LIVING CELLS | Non-Final OA | Ohio State Innovation Foundation |
| 18291773 | Methods and Compositions for Producing Cell-Source Identifiable Collections of Nucleic Acids | Non-Final OA | Takara Bio USA, Inc. |
| 18408191 | SYSTEM FOR THE DIRECTED EVOLUTION OF BIOMOLECULES IN MULTI-BODY COMPLEXES | Non-Final OA | Massachusetts Institute of Technology |
| 18396156 | Digital Analysis of Circulating Tumor Cells in Blood Samples | Final Rejection | The General Hospital Corporation |
| 18702311 | PRE-LIBRARY TARGET ENRICHMENT FOR NUCLEIC ACID SEQUENCING | Non-Final OA | University of Utah Research Foundation |
| 18253250 | TARGETING HOST-BACTERIA INTERACTIONS FOR THE TREATMENT OF MICROBIOTA-MEDIATED DISEASES | Non-Final OA | YALE UNIVERSITY |
| 18230872 | TESTING COLON CANCER DRUGS FOR IMMUNOMODULATORY EFFECTS | Non-Final OA | BROWN UNIVERSITY |
| 18580463 | SCREENING CODON-OPTIMIZED NUCLEOTIDE SEQUENCES | Non-Final OA | TRANSLATE BIO, INC. |
| 18025100 | ARRAY, SOAKING SOLUTIONS AND METHOD OF SELECTING SOAKING CONDITIONS FOR SMALL MOLECULES IN BIOLOGICAL MACROMOLECULAR CRYSTALS | Final Rejection | CRYSTALSFIRST GMBH |
| 18025103 | ARRAY, SOAKING SOLUTIONS AND METHOD OF SELECTING SOAKING CONDITIONS FOR SMALL MOLECULES IN BIOLOGICAL MACROMOLECULAR CRYSTALS | Final Rejection | CRYSTALSFIRST GMBH |
| 18025107 | ARRAY, SOAKING SOLUTIONS AND METHOD OF SELECTING SOAKING CONDITIONS FOR SMALL MOLECULES IN BIOLOGICAL MACROMOLECULAR CRYSTALS | Final Rejection | CRYSTALSFIRST GMBH |
| 17702643 | VARIANT NUCLEIC ACID LIBRARIES FOR TIGIT | Final Rejection | Twist Bioscience Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy